BioNTech SE BNTX
90.70 USD +3.78 (+4.35%)
At closeNov 4, 2026, 5:06 PM EST
89.90 -0.80 -0.88%
After hours · Nov 4, 5:06 PM ET
88.25 Day range 91.46
79.52 52-week range 124.00
- YTD
- -4.73%
- 1 year
- -13.48%
Analyst view
Consensus: buy
Buy
Price target (mean) 116.64 +28.6% upside
Now 90.70
- Target (low)
- 76.24
- Target (mean)
- 116.64
- Target (high)
- 144.65
Ratings (0m) 21 14 buy · 7 hold · 0 sell
- Strong buy1
- Buy13
- Hold7
- Sell0
- Strong sell0
Recommendation trend
- This month 21
- 1 month ago 21
- 2 months ago 20
- 3 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.35 | -2.35 – -2.35 | -0.33 | -613.6% | 500.32M | -44.9% | 1 |
| Next quarter | -1.70 | -1.70 – -1.70 | -1.95 | +12.8% | 153.60M | +30.1% | 1 |
| Current year | -4.75 | -5.18 – -4.49 | -0.48 | -888.9% | 1.78B | -38.1% | 8 |
| Next year | -4.86 | -7.69 – -3.07 | -4.75 | -2.5% | 1.80B | +1.3% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 4, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Nov 4, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Nov 4, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 14, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Oct 7, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 8, 2026 | BMO Capital | Downgrade | Outperform | Market Perform |
| Aug 31, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 5, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 5, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Jul 8, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 27, 2026 | UBS | Upgrade | Neutral | Buy |
| May 22, 2026 | Bernstein | Initiated | — | Market Perform |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| May 6, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 27, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 10, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 31, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 11, 2026 | Canaccord Genuity | Maintained | Buy | Buy |
| Mar 11, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 11, 2026 | TD Cowen | Maintained | Hold | Hold |
| Mar 11, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Mar 10, 2026 | Jefferies | Maintained | Buy | Buy |
| Jan 16, 2026 | Goldman Sachs | Upgrade | Neutral | Buy |
| Nov 10, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Oct 23, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Oct 10, 2025 | Morgan Stanley | Maintained | Overweight | Overweight |
| Sep 22, 2025 | JP Morgan | Maintained | Neutral | Neutral |
| Sep 8, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |